Increased Transforming Growth Factor- Levels Associated With Cardiac Adverse Events in Hypertrophic Cardiomyopathy


Creative Commons License

Ayca B., Sahin I., Kucuk S. H., Akin F., Kafadar D., Avsar M., ...More

CLINICAL CARDIOLOGY, vol.38, no.6, pp.371-377, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 38 Issue: 6
  • Publication Date: 2015
  • Doi Number: 10.1002/clc.22404
  • Journal Name: CLINICAL CARDIOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.371-377
  • Open Archive Collection: AVESIS Open Access Collection
  • Istanbul University-Cerrahpasa Affiliated: No

Abstract

BackgroundHypertrophic cardiomyopathy (HCM) is a common genetic heart disease characterized by ventricular hypertrophy, myocardial fibrosis, and impaired ventricular relaxation. The exact mechanisms by which fibrosis is caused remain unknown.